Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia population

Br J Haematol. 2023 Jul;202(1):e3-e6. doi: 10.1111/bjh.18844. Epub 2023 May 2.

Andrew Doan^{1

2}, Holly K T Huang³, Ari J Hadar⁴, Jemily Malvar², Teresa Rushing⁵, Gordana Raca^{1

6}, Alexandra E Kovach^{1

6}, David R Freyer^{1

2}, Chintan Parekh^{1

2}, Jamie Stokke^{1

2}, Leila C Posch^{1

7}, Julie Dao⁵, Deepa Bhojwani^{1

2}, Paul Gaynon^{1

2}, Etan Orgel^{1

2}

¹ Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
² Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California, USA.
³ David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
⁴ University South Florida, Tampa, Florida, USA.
⁵ Department of Pharmacy, Children's Hospital Los Angeles, Los Angeles, California, USA.
⁶ Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.
⁷ Division of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, California, USA.

No abstract available

Publication types